Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 225

1.

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study.

Fadini GP, Li Volsi P, Devangelio E, Poli M, Cazzetta G, Felace G, Avogaro A; DARWIN-T2D Network.

J Endocrinol Invest. 2019 Sep 12. doi: 10.1007/s40618-019-01110-w. [Epub ahead of print]

PMID:
31515744
2.

Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives.

Cӑtoi AF, Vodnar DC, Corina A, Nikolic D, Citarrella R, Pérez-Martínez P, Rizzo M.

Curr Pharm Des. 2019;25(18):2038-2050. doi: 10.2174/1381612825666190708190437.

PMID:
31298152
3.

Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study.

Fadini GP, Sciannameo V, Franzetti I, Bottigliengo D, D'Angelo P, Vinci C, Berchialla P, Arena S, Buzzetti R, Avogaro A; DARWIN-T2D network.

Diabetes Obes Metab. 2019 Aug;21(8):1886-1894. doi: 10.1111/dom.13747. Epub 2019 May 8.

PMID:
30985052
4.

Advances in pharmacological treatment of type 1 diabetes during pregnancy.

Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N.

Expert Opin Pharmacother. 2019 Jun;20(8):983-989. doi: 10.1080/14656566.2019.1593372. Epub 2019 Mar 29. Review.

PMID:
30924387
5.

Psoriasis and acute coronary syndrome risk.

Sachinidis A, Nikolic D, Rizzo M, Cianflone D.

Int J Cardiol. 2019 Jul 1;286:15-16. doi: 10.1016/j.ijcard.2019.02.042. Epub 2019 Feb 22. No abstract available.

PMID:
30878239
6.

Microvascular and macrovascular effects of liraglutide.

Cianflone D, Rizvi AA, Rizzo M.

Int J Cardiol. 2019 Jul 1;286:17-18. doi: 10.1016/j.ijcard.2019.02.041. Epub 2019 Feb 25. No abstract available.

PMID:
30878237
7.

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin.

Geagea AG, Rizzo M, Jurjus A, Cappello F, Leone A, Tomasello G, Gracia C, Al Kattar S, Massaad-Massade L, Eid A.

Oncotarget. 2019 Feb 12;10(13):1284-1305. doi: 10.18632/oncotarget.26641. eCollection 2019 Feb 12.

8.

Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials.

Fogacci F, Banach M, Mikhailidis DP, Bruckert E, Toth PP, Watts GF, Reiner Ž, Mancini J, Rizzo M, Mitchenko O, Pella D, Fras Z, Sahebkar A, Vrablik M, Cicero AFG; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP).

Pharmacol Res. 2019 May;143:1-16. doi: 10.1016/j.phrs.2019.02.028. Epub 2019 Mar 4. Review.

PMID:
30844537
9.

Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.

Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M.

Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10.

PMID:
30759365
10.

Future perspectives of the pharmacological management of diabetic dyslipidemia.

Patti AM, Giglio RV, Papanas N, Rizzo M, Rizvi AA.

Expert Rev Clin Pharmacol. 2019 Feb;12(2):129-143. doi: 10.1080/17512433.2019.1567328. Epub 2019 Jan 22. Review.

PMID:
30644763
11.

Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

Fogacci F, Grassi D, Rizzo M, Cicero AFG.

Phytother Res. 2019 Apr;33(4):862-870. doi: 10.1002/ptr.6282. Epub 2019 Jan 10. Review.

12.

Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas?

Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N.

Ann Transl Med. 2018 Nov;6(Suppl 1):S79. doi: 10.21037/atm.2018.10.60. No abstract available.

13.

Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study.

Penson P, Long DL, Howard G, Howard VJ, Jones SR, Martin SS, Mikhailidis DP, Muntner P, Rizzo M, Rader DJ, Safford MM, Sahebkar A, Toth PP, Banach M.

Cardiovasc Res. 2019 Jan 1;115(1):204-212. doi: 10.1093/cvr/cvy198.

PMID:
30576432
14.

Periodontitis and mechanisms of cardiometabolic risk: Novel insights and future perspectives.

Mesa F, Magan-Fernandez A, Castellino G, Chianetta R, Nibali L, Rizzo M.

Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):476-484. doi: 10.1016/j.bbadis.2018.12.001. Epub 2018 Dec 5. Review.

PMID:
30529255
15.

Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children.

Nikolic D, Corina A, Toth PP, Hammad L, Rizzo M.

Expert Opin Pharmacother. 2019 Feb;20(3):241-244. doi: 10.1080/14656566.2018.1552942. Epub 2018 Dec 6. No abstract available.

PMID:
30521406
16.

Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis.

Marchesini G, Pasqualetti P, Anichini R, Caputo S, Memoli G, Ponzani P, Resi V, Rizzo M, Serviddio G, Zanette G.

Acta Diabetol. 2019 Mar;56(3):289-299. doi: 10.1007/s00592-018-1236-6. Epub 2018 Oct 10.

PMID:
30306406
17.

Pharmacotherapy for gestational diabetes.

Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N.

Expert Opin Pharmacother. 2018 Sep;19(13):1407-1414. doi: 10.1080/14656566.2018.1509955. Epub 2018 Aug 23. Review.

PMID:
30136869
18.

Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study.

Fadini GP, Solini A, Manca ML, Zatti G, Karamouzis I, Di Benedetto A, Frittitta L, Avogaro A; DARWIN-T2D Network.

Acta Diabetol. 2018 Nov;55(11):1121-1129. doi: 10.1007/s00592-018-1194-z. Epub 2018 Aug 9.

PMID:
30090961
19.

The Role of Nutraceuticals in Statin Intolerant Patients.

Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov M, Fras Z, von Haehling S, Katsiki N, Langlois M, Latkovskis G, Mancini GBJ, Mikhailidis DP, Mitchenko O, Moriarty PM, Muntner P, Nikolic D, Panagiotakos DB, Paragh G, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Rosano GMC, Rosenson RS, Rysz J, Sahebkar A, Serban MC, Vinereanu D, Vrablík M, Watts GF, Wong ND, Rizzo M; International Lipid Expert Panel (ILEP).

J Am Coll Cardiol. 2018 Jul 3;72(1):96-118. doi: 10.1016/j.jacc.2018.04.040. Review.

20.

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study.

Fadini GP, Bottigliengo D, D'Angelo F, Cavalot F, Bossi AC, Zatti G, Baldi I, Avogaro A; DARWIN-T2D Network.

Diabetes Ther. 2018 Aug;9(4):1477-1490. doi: 10.1007/s13300-018-0452-y. Epub 2018 Jun 1.

Supplemental Content

Loading ...
Support Center